Fulcrum Therapeutics, Inc. (FULC) › Total LiabilitiesFulcrum Therapeutics, Inc. (FULC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2018: $9.77M2019: $23.29M2020: $34.40M2021: $23.46M2022: $27.74M2023: $22.50M2024: $17.68M2025: $17.28M$17.28M2018Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$17.28M-2.3%2024$17.68M-21.4%2023$22.50M-18.9%2022$27.74M+18.3%2021$23.46M-31.8%2020$34.40M+47.7%2019$23.29M+138.3%2018$9.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share